Skip to content

Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes

Self-compassion to Reduce Diabetes Distress in Persons With Type 1 Diabetes

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05070949
Enrollment
34
Registered
2021-10-07
Start date
2022-01-01
Completion date
2023-11-07
Last updated
2025-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Keywords

self-compassion, diabetes distress, sleep

Brief summary

This study explored the effects of self-compassion intervention on diabetes distress and self-compassion.

Detailed description

This study tests the effects of a 12-week mindful self-compassion (MSC) program in people with type 1 diabetes. Eighty participants will be randomized to the MSC program or be in a wait-list control group. Measures of primary outcome are self-compassion and diabetes- distress. Secondary outcomes are hemoglobin A1C, diabetes self-efficacy, stress and depression symptoms, and sleep quality. Outcomes will be measured at baseline, 12 weeks (end of the program) and 24 weeks (post program).

Interventions

Bi-weekly meeting will involve six lessons: What is Self-Compassion , Practicing Self-Compassion, Discovering your Compassionate Voice, Self-Compassion and Resilience , Self-Compassion and Burnout and Making it Count

Sponsors

Chulalongkorn University
CollaboratorOTHER
Mahidol University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* type 1 diabetes, age 18-30 * own computer or tablet with access to internet for meetings * willingness to complete all 6 sessions

Exclusion criteria

* history of self-harm or suicide attempt in the pat one year * severe diabetic complications such as dialysis or blindness * unstable depression, requiring ongoing medication adjustment within the last 3 months * A1C \> 11% * Severe hypoglycemia requiring emergency room visit or hospitalization in the past 6 months * History of Diabetic Ketoacidosis requiring hospitalization in the past 3 months * pregnant or intend to get pregnant during the study timeframe

Design outcomes

Primary

MeasureTime frameDescription
Diabetes distressbaseline to 24 weeksDiabetes distress will be evaluated by a questionnaire. Each item is rated on a 6-point Likert scale from 1 (no problem) to 6 (serious problems). Scores range from 17 to 102, which the higher scores indicate the higher diabetes distress levels (A worse outcome).
Self-compassionbaseline to 24 weeksSelf-compassion will be evaluated by a questionnaire. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Scores range from 26 to 130, which the higher scores indicate the higher self-compassion levels (A better outcome). This outcome is reported in the mean difference of self-compassion score between two groups.

Secondary

MeasureTime frameDescription
Diabetes Self-efficacybaseline to 24 weeksDiabetes self-efficacy will be measured by questionnaire. Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Scores range from 19 to 95, which the higher scores indicate the higher self-efficacy levels (A better outcome).
Hemoglobin A1Cbaseline and 12 weeksHbA1c will be obtained by blood test.
Sleep qualitybaseline to 24 weeksSleep quality will be measured by a questionnaire. Each item is rated on a 4-point Likert scale from 0 (very good) to 3 (very bad). Scores range from 0 to 21, which the higher scores indicate poor sleep quality (A worse outcome).
Stress and depressive symptomsbaseline to 24 weeksstress and depressive symptoms will be measured by a questionnaire. Each item is rated on a 5-point Likert scale from 0 (never) to 4 (very often). Scores range from 0 to 40, which the higher scores indicate higher stress and depression (A worse outcome). This outcome is reported in the mean difference of stress and depression score between two groups.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026